A novel role of lysophosphatidic acid (LPA) in human myeloma resistance to proteasome inhibitors;
Su, P, Xiao, L, Ye, L, Wang, Z, Xiong, W, Wang, Q, Ma, X, Xian, M, Yang, M, Zu, Y, Pingali, SR, Qian, J & Yi, Q 2022, , Journal of Hematology and Oncology, vol. 15, no. 1, 55.

Functional expression of opioid receptors and other human GPCRs in yeast engineered to produce human sterols;
Bean, BDM, Mulvihill, CJ, Garge, RK, Boutz, DR, Rousseau, O, Floyd, BM, Cheney, W, Gardner, EC, Ellington, AD, Marcotte, EM, Gollihar, JD, Whiteway, M & Martin, VJJ 2022, , Nature Communications, vol. 13, no. 1, 2882.

Papillary Fibroelastoma Incidentally Found on Left Atrial Wall During Minimally Invasive Aortic Valve Replacement;
Al Abri, Q, El Nihum, LI, Mujeeb Zubair, M, Barrios, R, Reardon, MJ & Ramchandani, M 2022, , Texas Heart Institute Journal, vol. 49, no. 4.

CD44 receptor targeted nanoparticles augment immunity against tuberculosis in mice;
Singh, VK, Chau, E, Mishra, A, DeAnda, A, Hegde, VL, Sastry, JK, Haviland, D, Jagannath, C, Godin, B & Khan, A 2022, , Journal of Controlled Release, vol. 349, pp. 796-811.

Recurrent Gastrointestinal Bleeding in a Middle-Aged Man;
Gowani, F, Phillips, B, Leveque, C, Castillo, B, Chen, J, Chandler, W, Rice, L & Salazar, E 2022, , Laboratory Medicine, vol. 53, no. 4, pp. e91-e94.

A Century of Progress;
Bertholf, RL & Kroft, SH 2022, , Laboratory Medicine, vol. 53, no. 4, pp. 333-335.

A Century of Progress;
Bertholf, RL & Kroft, SH 2022, , American Journal of Clinical Pathology, vol. 158, no. 1.

Comparison of LACE and HOSPITAL Readmission Risk Scores for CMS Target and Nontarget Conditions;
Jones, SL, Cheon, O, Manzano, JGM, Park, AK, Lin, HY, Halm, JK, Baek, J, Graviss, EA, Nguyen, DT, Kash, BA & Phillips, RA 2022, , American Journal of Medical Quality, vol. 37, no. 4, pp. 299-306.

Managing Manganese: The Role of Manganese Homeostasis in Streptococcal Pathogenesis;
Aggarwal, S & Kumaraswami, M 2022, , Frontiers in Cell and Developmental Biology, vol. 10, 921920.

Antibody-Mediated LILRB2-Receptor Antagonism Induces Human Myeloid-Derived Suppressor Cells to Kill Mycobacterium tuberculosis;
Singh, VK, Khan, A, Xu, Y, Mai, S, Zhang, L, Mishra, A, Restrepo, BI, Pan, PY, Chen, SH & Jagannath, C 2022, , Frontiers in immunology, vol. 13, 865503.